Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea

Aviv D Goldbart1, Maria C Veling, Julie L Goldman

  • 1Department of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, 570 South Preston Street, Suite 321, Louisville, KY 40202, USA.

Pediatric Research
|December 22, 2004
PubMed

Insights

Glucocorticoid receptors (GCR) are present in children's adenotonsillar tissue. Higher GCR-alpha expression in obstructive sleep apnea (OSA) patients suggests topical steroid therapy may benefit these children.

Area of Science:

  • Pediatric Otolaryngology
  • Molecular Biology
  • Sleep Medicine

Background:

  • Tonsillectomy and adenoidectomy (T&A) is common for pediatric obstructive sleep apnea (OSA).
  • Topical steroid therapy may benefit children with OSA symptoms not meeting T&A criteria.
  • Glucocorticoid receptor (GCR) expression in adenoid and tonsil tissue is uncharacterized.

Purpose of the Study:

  • To investigate and compare the expression patterns of human GCR isoforms in pediatric adenotonsillar tissues.
  • To determine if GCR expression differs between children with OSA and those with recurrent throat infections (RI).

Main Methods:

  • Quantitative PCR, immunohistochemistry, and Western blotting were used to analyze GCR-alpha and GCR-beta expression.
  • Adenotonsillar tissues from 36 children (OSA or RI) were analyzed.
  • Specific primers and antibodies were employed for GCR isoforms.

Main Results:

  • Both GCR-alpha and GCR-beta mRNA were detected in all adenotonsillar tissues, with GCR-alpha being more abundant.
  • GCR-alpha mRNA expression was significantly higher in tissues from children with OSA compared to RI.
  • Protein expression analysis confirmed higher GCR-alpha levels in OSA patients, with distinct topographic distribution patterns for both GCR isoforms.

Conclusions:

  • Glucocorticoid receptors (GCR-alpha and GCR-beta) are expressed in pediatric adenotonsillar tissues.
  • Increased GCR-alpha expression in OSA patients suggests potential efficacy of topical steroid treatment.
  • The high GCR-alpha to GCR-beta ratio supports topical steroid therapy for children with adenotonsillar hypertrophy and snoring.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...